Does Anti-Mllerian Hormone Predict Outcome of Pregnancy in Women with Recurrent Miscarriage?.
To evaluate the prognostic value of anti- Millerian hormone (AAMH) on the outcome of pregnancy in women with recurrent miscarriage (RM). Retrospective cohort study; data from 98 women with unexplained RM were analyzed. The serum AMH and follicle-stimulating hormone (FSH) concentrations prior to and within 6 months of conception were determined with enzyme-linked immu-" nosorbent assay (ELISA) on day 2-6 of a cycle. There was no difference in AMH or FSH results between those who had live birth or miscarriage. Neither AMH nor FSH results had any significant prognostic value on the outcome of the pregnancy. AMH and FSH on their own do not seem to predict the outcome of pregnancy in women with unexplained recurrent miscarriage.